CARDIOVASCULAR JOURNAL OF AFRICA • Volume 25, No 1, January/February 2014
32
AFRICA
cular mortality in middle-aged men.
J Am Med Assoc
2002;
288
(21):
2709–2716.
2.
Ford ES. Risks for all-cause mortality, cardiovascular, and diabetes
associated with the metabolic syndrome: a summary of the evidence.
Diabetes Care
2005;
28
(7): 1769–1778.
3.
Alberti KG MM, Zimmet PZ. Definition, diagnosis and classification
of diabetes mellitus and its complications. Part 1: diagnosis and classi-
fication of diabetes mellitus provisional report of a WHO consultation.
Diabet Med
1998;
15
(7): 539–553.
4.
Expert panel on detection, evaluation, and treatment of high blood
cholesterol in adults. Executive summary of the third report of the
National Cholesterol Educational Program (NCEP) expert panel
on detection, evaluation, and treatment of high blood cholesterol in
adults (Adult Treatment Panel III).
J Am Med A
ssoc 2001;
285
(19):
2486–2497.
5.
Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome: a new
world-wide definition. A Consensus Statement from the International
Diabetes Federation.
Diabet Med
2006;
23
: 469–480.
6.
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome.
Lancet
2005;
365
(9468): 1415–1428.
7.
Alberti KG MM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman
JI, Donato KA,
et al
. Harmonizing the metabolic syndrome: A
joint interim statement of the International Diabetes Federation task
force on epidemiology and prevention; National Heart, Lung, and
Blood Institute; American Heart Association; World Heart Federation;
International Atherosclerosis Society; and International Association for
the Study of Obesity.
Circulation
2009;
120
: 1640–1645.
8.
Grundy SM. Metabolic syndrome pandemic.
Arterioscler Thromb Vasc
Biol
2008;
28
: 629–636.
9.
World Health Organisation. Non-Communicable Diseases: A Strategy
for the African Region. Harare, Zimbabwe: WHO Regional Office for
Africa; 2000.
10. Yusuf S, Reddy S, Ounpuu S, Anand S
.
Global burden of cardiovascular
diseases: part I: general considerations, the epidemiologic transition,
risk factors, and impact of urbanization.
Circulation.
2001;
104
(22):
2746–2753.
11. Okafor IC. The metabolic syndrome in Africa: Current trends
.
Indian J
Endocrinol Metab
2012;
16
(1): 56–66.
12. Makuyana D, Gomo Z, Munyombwe T, Matenga JA, Hakim JG.
Metabolic syndrome disorders in urban black Zimbabweans with type
2 Diabetes mellitus.
Cent Afr J Med
2004;
50
(3–4): 24–29.
13. Ntyintyane LM, Panz VR, Raal FJ, Gill GV. Metabolic syndrome,
undiagnosed diabetes mellitus and insulin resistance are highly preva-
lent in urbanised South African blacks with coronary artery disease.
Cardiovasc J S Afr
2006;
17
(2): 50–55.
14. Fezeu L, Balkau B, Kengne AP, Sobngwi E, Mbanya J-C. Metabolic
syndrome in a sub-Saharan African setting: central obesity may be the
key determinant.
Atherosclerosis
2007;
193
: 70–76.
15. Ker JA, Rheeder P, Van Tonder R
.
Frequency of the metabolic syndrome
in screened South African corporate executives.
Cardiovasc J South Afr
2007;
18
: 30–33.
16. Ntandou G, Delisle H, Agueh V, Fayomi B. Abdominal obesity explains
the positive rural-urban gradient in the prevalence of the metabolic
syndrome in Benin, West Africa.
Nutr Res
2009;
29
: 180–189.
17. Oladapo OO, Salako L, Sodiq O, Shoyinka K, Adedapo K, Falase AO. A
prevalence of cardiometabolic risk factors among a rural Yoruba south-
western Nigerian population: a population-based survey.
Cardiovasc J
Afr
2010;
21
(1):
26–31.
18. Motala A, Esterhuizen T, Pirie FJ, Omar MAK. The prevalence of
metabolic syndrome and determination of the optimal waist circumfer-
ence cut-off points in a rural South African Community.
Diabetes Care
2011;
34
: 1032–1037.
19. Akpalu J, Akpalu A, Ofei F. The metabolic syndrome among patients
with cardiovascular disease in Accra, Ghana.
Ghan Med J
2011;
45
(4):
161–166.
20. Kaduka LU, Kombe Y, Kenya E, Kuria E, Bore JK, Bukania ZN,
Mwangi M. Prevalence of metabolic syndrome among an urban popula-
tion in Kenya.
Diabetes Care
2012;
35
(4): 887–893.
21. Kengne AP, Limen SN, Sobngwi E, Djouogo CFT, Nouedoui C.
Metabolic syndrome in type 2 diabetes: comparative prevalence accord-
ing to two sets of diagnostic criteria in sub-Saharan Africans.
Diabet
Metab Synd
2012;
4
: 22.
22. Balkau B, Charles MA. Comment on the provisional report of WHO
consultation. European Group for the Study of Insulin Resistance
(EGIR).
Diabet Med 1999
;
16
: 442–443.
23. Lin WY, Lee LT, Chen CY, Lo H, Hsia HH, Liu IL, Lin RS, Shau WY,
Huang KC. Optimal cut-off values for obesity: using simple anthropo-
metric indices to predict cardiovascular risk factors in Taiwan.
In J Obes
Relat Metab Disord
2002;
26
: 1232– 1238.
24. Prinsloo J, Malan L, de Ridder JH, Potgieter JC, Steyn HS. Determining
the waist circumference cut-off which best predicts the metabolic
syndrome components in urban Africans: The SABPA Study.
Exp Clin
Endocrinol Diabetes
2011;
119
: 599–603
25. Crowther NJ, Norris SA. The current waist circumference cut point
used for the diagnostic of metabolic syndrome in Sub-Saharan African
women is not appropriate.
PLOS One
2012;
7
(11): 1–8.
26. Magalhães P, Capingana DP, Silva ABT, Ferreira AVL, Sá Cunha R,
Rodrigues SL, et al. Age- and gender-specific reference values of pulse
wave velocity for African adults: Preliminary results.
Age
2013;
35
:
2345- 2355.
27. Capingana DP, Magalhães P, Silva ABT, Gonçalves MAA, Baldo MP,
Rodrigues SL, Simões CCF, Ferreira AVL, Mill JG. Prevalence of
cardiovascular risk factors and socioeconomic level among public-
sector workers in Angola.
BMC Public Health
2013;
13
: 732
28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentra-
tion of low-density lipoprotein cholesterol in plasma, without use of the
preparative ultracentrifuge.
Clin Chem
1972;
18
: 499–502.
29. Pereira AC, Sposito AC, Mota GF, Cunha RS, Herkenhoff FL, Mill
JG,
et al.
Endothelial nitric oxide synthase gene variant modulates the
relationship between serum cholesterol levels and blood pressure in the
general population: new evidence for a direct effect of lipids in arterial
blood pressure.
Atherosclerosis
2006;
184
(1): 193–200.
30. Lean MEJ, Han TS, Morrison CE. Waist circumference as a measure for
indicating need for weight management.
Br Med J
1995;
311
: 158–161.
31. World Health Organisation. Obesity: Preventing and managing the
global epidemic: Report of a WHO Consultation on Obesity, Geneva,
3–5 June 1997. Geneva (CH): World Health Organisation, 1998. http://
whqlibdoc.who.int/hq/1998/WHO_NUT_NCD_98.1_(p1-158).pdf.
Accessed 03 January 2013.
32. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue
M. Age standardization of rates. A newWHO standard. EIP/GPE/EBD.
GPE discussion paper Series. WHO 2001;
31
: 1–14.
33. Youden WJ. An index for rating diagnostic tests.
Cancer
1950;
3
:
32–35.
34. Sumner AE, Zhou J, Doumatey A, Imoisili OE, Amoah A, Acheampong
J,
et al
. Low HDL-cholesterol with normal triglycerides levels is the
most common lipid pattern in West Africans and African Americans
with metabolic syndrome: Implications for cardiovascular disease
prevention.
CVD Prev Control
2010;
5
(3): 75–80.
35. Fezeu L, Mincoulou E, Balkau B, Kengne AP, Awah P, Unwin N,
et
